Necrosis-avid contrast agents: introducing nonporphyrin species.

[1]  A L Baert,et al.  Paramagnetic metalloporphyrins: from enhancers of malignant tumors to markers of myocardial infarcts. , 1996, Academic radiology.

[2]  P. Furmanski,et al.  Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice. , 1988, Cancer research.

[3]  G. Marchal,et al.  Metalloporphyrin enhanced magnetic-resonance-imaging of acute myocardial-infarction , 1994 .

[4]  A. Kopp,et al.  Liver-specific contrast media: a magic bullet or a weapon for dedicated targets? , 1997, Radiology.

[5]  J. Sessler,et al.  Preclinical Evaluation of Gadolinium (III) Texaphyrin Complex: A New Paramagnetic Contrast Agent for Magnetic Resonance Imaging , 1994, Investigative radiology.

[6]  U Schmiedl,et al.  Metalloporphyrins as tumor-seeking MRI contrast media and as potential selective treatment sensitizers. , 1990, Investigative radiology.

[7]  Y. Ni,et al.  Validation of intracoronary delivery of metalloporphyrin as an in vivo "histochemical staining" for myocardial infarction with MR imaging. , 1998, Academic radiology.

[8]  H. Bosmans,et al.  Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI , 2004, European Radiology.

[9]  J Bogaert,et al.  Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. , 1999, Circulation.

[10]  A L Baert,et al.  Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis. , 1997, Investigative radiology.

[11]  R. van Hillegersberg,et al.  Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. , 1992, Gastroenterology.

[12]  S. Okada,et al.  Role of serum albumin as a carrier of 99mTc-complex to tumor tissue. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[13]  R. Lauffer,et al.  Targeted relaxation enhancement agents for MRI , 1991, Magnetic resonance in medicine.

[14]  Thierry Patrice,et al.  Tetra‐p‐aminophenylporphyrin conjugated with Gd‐DTPA: Tumor‐specific contrast agent for MR imaging , 1993, Journal of magnetic resonance imaging : JMRI.

[15]  A L Baert,et al.  Localization of metalloporphyrin-induced "specific" enhancement in experimental liver tumors: comparison of magnetic resonance imaging, microangiographic, and histologic findings. , 1995, Academic radiology.

[16]  R. Weissleder,et al.  Mechanism of gadophrin‐2 accumulation in tumor necrosis , 1999, Journal of magnetic resonance imaging : JMRI.